Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne V Frankfort

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Clinical Pharmacology|September 11, 2008
Serum amyloid beta peptides in patients with dementia and age-matched non-demented controls as detected by surface-enhanced laser desorption ionisation-time of flight mass spectrometry (SELDI-TOF MS)Suzanne V Frankfort, Jos P C M van Campen, Linda R Tulner, et al.
Rapid Communications in Mass Spectrometry : RCM|October 18, 2006
A simple and sensitive assay for the quantitative analysis of rivastigmine and its metabolite NAP 226-90 in human EDTA plasma using coupled liquid chromatography and tandem mass spectrometrySuzanne V Frankfort, Mariët Ouwehand, Maria J van Maanen, et al.
Pharmacoepidemiology and Drug Safety|January 5, 2006
The effect of admission to a geriatric ward on medication use: 2002 versus 1985Suzanne V Frankfort, Linda R Tulner, Jos P C M van Campen, et al.
Clinical Drug Investigation|December 14, 2006
Evaluation of pharmacotherapy in geriatric patients after performing complete geriatric assessment at a diagnostic day clinicSuzanne V Frankfort, Linda R Tulner, Jos P C M van Campen, et al.
Current Clinical Pharmacology|May 16, 2009
Do geriatric outpatients adhere to medication changes advised after assessment? An exploratory pilot studyLinda R Tulner, Suzanne V Frankfort, Floor Wesselius, et al.
Current Clinical Pharmacology|August 15, 2008
Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literatureSuzanne V Frankfort, Linda R Tulner, Jos P C M van Campen, et al.
Molecular Neurodegeneration|September 27, 2006
ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patientsSuzanne V Frankfort, Valerie D Doodeman, Remco Bakker, et al.
Drugs & Aging|March 26, 2008
Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevanceLinda R Tulner, Suzanne V Frankfort, George J P T Gijsen, et al.
International Journal of Geriatric Psychiatry|November 30, 2005
Discontinuation of rivastigmine in routine clinical practiceSuzanne V Frankfort, Bregje A Appels, Anthonius de Boer, et al.
Drugs & Aging|October 2, 2010
Changes in under-treatment after comprehensive geriatric assessment: an observational studyLinda R Tulner, Jos P C M van Campen, Suzanne V Frankfort, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Clinical Pharmacology|September 11, 2008
Serum amyloid beta peptides in patients with dementia and age-matched non-demented controls as detected by surface-enhanced laser desorption ionisation-time of flight mass spectrometry (SELDI-TOF MS)Suzanne V Frankfort, Jos P C M van Campen, Linda R Tulner, et al.
Rapid Communications in Mass Spectrometry : RCM|October 18, 2006
A simple and sensitive assay for the quantitative analysis of rivastigmine and its metabolite NAP 226-90 in human EDTA plasma using coupled liquid chromatography and tandem mass spectrometrySuzanne V Frankfort, Mariët Ouwehand, Maria J van Maanen, et al.
Pharmacoepidemiology and Drug Safety|January 5, 2006
The effect of admission to a geriatric ward on medication use: 2002 versus 1985Suzanne V Frankfort, Linda R Tulner, Jos P C M van Campen, et al.
Clinical Drug Investigation|December 14, 2006
Evaluation of pharmacotherapy in geriatric patients after performing complete geriatric assessment at a diagnostic day clinicSuzanne V Frankfort, Linda R Tulner, Jos P C M van Campen, et al.
Current Clinical Pharmacology|May 16, 2009
Do geriatric outpatients adhere to medication changes advised after assessment? An exploratory pilot studyLinda R Tulner, Suzanne V Frankfort, Floor Wesselius, et al.
Current Clinical Pharmacology|August 15, 2008
Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literatureSuzanne V Frankfort, Linda R Tulner, Jos P C M van Campen, et al.
Molecular Neurodegeneration|September 27, 2006
ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patientsSuzanne V Frankfort, Valerie D Doodeman, Remco Bakker, et al.
Drugs & Aging|March 26, 2008
Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevanceLinda R Tulner, Suzanne V Frankfort, George J P T Gijsen, et al.
International Journal of Geriatric Psychiatry|November 30, 2005
Discontinuation of rivastigmine in routine clinical practiceSuzanne V Frankfort, Bregje A Appels, Anthonius de Boer, et al.
Drugs & Aging|October 2, 2010
Changes in under-treatment after comprehensive geriatric assessment: an observational studyLinda R Tulner, Jos P C M van Campen, Suzanne V Frankfort, et al.
Pageof 2